4,8,12,16,20,24,28-Heptaoxatritriacontane-1,2,6,10,14,18,22,26-octol,30,30,31,31,32,32,33,33-octafluoro- (62240-25-9)

Identification
Name:	4,8,12,16,20,24,28-Heptaoxatritriacontane-1,2,6,10,14,18,22,26-octol,30,30,31,31,32,32,33,33-octafluoro-
CAS:	62240-25-9
Molecular Formula:	C₂₆H₄₆F₈O₁₅
Molecular Structure:
Properties
Safety Data

Other Product

1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
(2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
11-benzyl-4-(butan-2-yl)-7,21,25-trimethyl-18-(2-methylpropyl)-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.1~5,8~.1~12,15~.1~19,22~]dotriaconta-1(28),5(32),12(31),14,19(30),26(29)-hexaene-2,9,16,23-tetrone
Peptide F (cattleadrenal medulla),1-de-L-tyrosine-2-deglycine-3-deglycine-4-de-L-phenylalanine-5-de-L-methionine-6-de-L-lysine-7-de-L-lysine-26-L-leucinamide-27-deglycine-28-de-L-lysine-29-de-L-arginine-30-de-L-tyrosine-31-deglycine-32-deglycine-33-de-L-phenylalanine-34-de-L-methionine-(9CI)
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
6,20-Dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),14,19(30),26(29),28-hexaene-2,9,16,23-tetrone,7,21-dimethyl-4,11-bis(1-methylethyl)-18-(1-methylpropyl)-25-(phenylmethyl)-,(4S,7R,8S,11R,18S,21R,22S,25R)- (9CI)
Neuropeptide Y (human),24-L-leucinamide-25-de-L-arginine-26-de-L-histidine-27-de-L-tyrosine-28-de-L-isoleucine-29-de-L-asparagine-30-de-L-leucine-31-de-L-isoleucine-32-de-L-threonine-33-de-L-arginine-34-de-L-glutamine-35-de-L-arginine-36-de-L-tyrosinamide-(9CI)
Formamide,N-[11-[16-[(aminocarbonyl)oxy]- 12-hydroxy-10,22-dimethoxy-11,14,21- trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,- 31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta- 2(31),4,6(30),8,24,26(29),28-heptaen-20-yl]-4,- 10-dimethoxy-3,5,9-trimethyl-6-oxo-1- undecenyl]-N-methyl-
Formamide,N-[4-(acetyloxy)-11-(16-hydroxy-22-methoxy-10,11,21-trimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,13,24,26(29),28-octaen-20-yl)-10-methoxy-5,9-dimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
Formamide,N-[11-[16-(acetyloxy)-12-hydroxy-10,22-dimethoxy-11,14,21-trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,24,26(29),28-heptaen-20-yl]-4,10-dimethoxy-3,5,9-trimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
6,20-Dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),14,19(30),26(29),28-hexaene-2,9,16,23-tetrone,7-methyl-11,25-bis(1-methylethyl)-4,18-bis[(1S)-1-methylpropyl]-,(4S,7R,8S,11R,18S,22S,25R)-
6,20-Dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),14,19(30),26(29),28-hexaene-2,9,16,23-tetrone,7,11,21-trimethyl-4,18-bis[(1S)-1-methylpropyl]-25-(phenylmethyl)-,(4S,7R,8S,11R,18S,21R,22S,25R)-
6,20-Dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),14,19(30),26(29),28-hexaene-2,9,16,23-tetrone,7-methyl-4,11,18-tris(1-methylethyl)-25-(phenylmethyl)-,(4S,7R,8S,11R,18S,22S,25R)- (9CI)
Formamide,N-[11-(14-amino-16-hydroxy- 10-methoxy-11,21-dimethyl-12,18-dioxo-3,7,- 19,27-tetraoxa-29,30,31-triazatetracyclo- [24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,24,- 26(29),28-heptaen-20-yl)-4,10-dimethoxy-5,- 9-dimethyl-6-oxo-1-undecenyl]-N-methyl-